Currier Plastics Forges Coast-to-Coast Medical Manufacturing Powerhouse

CHICAGO, IL – January 08, 2026 – In a decisive move that reshapes a key segment of the life sciences supply chain, New York-based Currier Plastics has acquired two California-based medical contract manufacturers, Springboard Manufacturing and MOS Plastics. The dual acquisitions, orchestrated by private equity owner Sheridan Capital Partners, instantly transform Currier from a regional specialist into a national powerhouse, establishing a critical coast-to-coast footprint in the highly specialized medical device manufacturing sector.

Backed by Sheridan Capital, a firm focused exclusively on the healthcare landscape, Currier will fully integrate both Springboard and MOS Plastics. While financial terms were not disclosed, the strategic value is clear: the deal combines three specialized firms into a single, more formidable entity. It significantly expands Currier’s manufacturing capacity, broadens its service offerings, and provides direct access to the vibrant West Coast life sciences market. The move is a strong indicator of an aggressive growth strategy intended to capture a larger share of the burgeoning medical device contract manufacturing market, an industry projected to grow at over 12% annually and surpass $150 billion by 2030.

A Strategic Leap to National Prominence

The acquisitions are geographically and operationally strategic. Springboard, based in Rancho Cordova, brings over 200 employees and a 140,000-square-foot campus. MOS Plastics, located in the heart of Silicon Valley in San Jose, adds another 120 employees and a 55,000-square-foot facility. Together, they give Currier a robust West Coast presence, placing it at the doorstep of the nation's largest hub for biotechnology and medical device innovation.

This new bicoastal operation addresses a long-standing logistical challenge for East Coast-based manufacturers, enabling the combined company to offer reduced lead times, lower shipping costs, and more responsive service to a vast customer base in California and the broader Pacific region. For medical device OEMs, proximity to manufacturing partners is often crucial for collaboration during design, prototyping, and production phases.

“Our customers will benefit from the addition of significant cleanroom capacity, adjacent services, a West Coast footprint, and strong expertise serving pharmaceutical, medical device and diagnostic customers,” said Currier CEO, Andrew McLean in a statement. His comments underscore the customer-centric rationale behind the expansion, aiming to create a more comprehensive and accessible partner for life sciences companies.

Bolstering Cleanroom Capacity and Precision Expertise

Beyond geography, the acquisitions represent a massive expansion of Currier’s technical capabilities, particularly in the high-stakes arena of cleanroom manufacturing. Springboard’s facilities include significant Class 8 cleanroom space, while MOS Plastics operates with both Class 7 and Class 8 cleanrooms. These controlled environments are essential for producing sterile, contamination-free plastic components used in critical medical and diagnostic devices, where patient safety is paramount.

The combined entity now boasts a powerful portfolio of services, including custom-molded precision components, advanced tooling, and complex sub-assemblies. This deepens Currier’s ability to function as a full-service Contract Development and Manufacturing Organization (CDMO), a model increasingly favored by medical device OEMs. By outsourcing complex manufacturing and assembly to a trusted partner, these companies can focus their resources on core activities like research, development, and marketing.

The integration of these capabilities positions the new Currier to meet the rising demand for increasingly complex, miniaturized, and high-precision medical products, from diagnostic test cartridges and drug delivery systems to surgical instruments.

The Private Equity Playbook: Sheridan Capital's Consolidation Strategy

This strategic roll-up is a classic example of a private equity “buy-and-build” strategy, expertly executed by Sheridan Capital Partners. By acquiring a solid platform company—Currier Plastics—and quickly adding complementary businesses, Sheridan is rapidly creating a more valuable and competitive enterprise. This approach is common in fragmented industries like medical contract manufacturing, where combining smaller, specialized players can unlock significant economies of scale and market power.

“The additions of Springboard and MOS will strengthen Currier’s position as a valued partner to a wider array of life sciences customers while also resulting in significant economies of scale,” noted Sean Dempsey, Co-founder and Partner at Sheridan. He highlighted the speed of the transaction, stating, “Completing these acquisitions so early in our ownership period accelerates our value creation plan for Currier.”

Signaling strong confidence in the merged entity's future, the former owner of Springboard, HC Private Investments, has rolled over its investment to become a material shareholder in the new, larger Currier. Furthermore, John Weber, the former CEO of Springboard, has joined the Currier Board of Directors, ensuring leadership continuity and institutional knowledge are carried forward. “Both Springboard and MOS will be better positioned to realize their full potential as part of Currier, benefiting from a dedicated sales force that neither business previously had, as well as operational resources that have enabled Currier to earn its strong reputation for quality and service,” Weber added.

Navigating Integration and Market Competition

The task ahead for Currier’s leadership is the complex process of fully integrating three distinct company cultures, standardizing quality systems across multiple states, and harmonizing operational processes to realize the promised synergies. Managing a newly bicoastal operation will introduce new logistical and communication challenges that must be addressed to maintain the high levels of quality and service all three companies are known for.

With an estimated combined revenue base approaching $50 million, the newly enlarged Currier Plastics is now better positioned to compete in a market that includes both niche specialists and divisions of global giants like Jabil and Flex. The company’s focused expertise in high-precision plastics and cleanroom molding for the life sciences provides a distinct competitive advantage against larger, more generalized manufacturers.

The success of this ambitious integration will ultimately depend on how effectively the combined entity can leverage its expanded geographic reach and technical capabilities. If executed well, the new Currier Plastics will not only provide enhanced value to its customers but also serve as a powerful platform for further growth and consolidation in the dynamic medical manufacturing industry.